VanEck Vectors Valuation

VanEck Vectors Biotech ETF -- USA Etf  

USD 119.00  0.19  0.16%

VanEck Vectors Biotech has current Real Value of $119.45 per share. The regular price of the etf is $119.0. At this time the etf appears to be fairly valued. Macroaxis measures value of VanEck Vectors Biotech from inspecting the etf fundamentals such as Number of Employees of 6, Five Year Return of 13.37% and Price to Earning of 17.66times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securites prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
VanEck Vectors Biotech ETF is rated below average in net asset as compared to similar ETFs. It is rated below average in price to earning as compared to similar ETFs . The ratio of Net Asset to Price to Earning for VanEck Vectors Biotech ETF is about  24,532,334 

Current Market Valuation

VanEck Vectors Biotech Valuation Boundaries
Fairly Valued
April 19, 2018
119.00
Market Value
Downside
114.92
119.45
Real Value
Target Price Odds
 Above  Below  
123.98
Upside
VanEck Vectors is not too risky asset. Calculation of real value of VanEck Vectors Biotech is based on 2 months time horizon. Increasing VanEck Vectors Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Net Asset

VanEck Vectors Net Asset Analysis
VanEck Vectors Biotech ETF is rated below average in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Sector category is currently estimated at about 159.4 Billion. VanEck Vectors adds roughly 433.24 Million in net asset claiming only tiny portion of equities under Sector ETF category.
Check also Trending Equities. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.